Clinical Trial Detail

NCT ID NCT02031536
Title Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors Eastern Cooperative Oncology Group
Indications

islet cell tumor

Therapies

Everolimus

Age Groups: adult

No variant requirements are available.